Chapel Hill, NC 27516
Chapel Hill, NC, November 14, 2011 --(PR.com)-- The Source-Omega company's invited manuscript was accepted after independent international peer review. It is published as an academic chapter in the book Environmental Pollution: Ecology and Human Health, published by Narosa (India) [http://www.narosa.com/books_display.asp?catgcode=978-81-8487-112-8].
Source-Omega maintains its R&D is always expanding and touts its public health research focus. They are seeking to identify the largest populations with the greatest omega-3 need.
Doughman's collaborations with senior medical and scientific experts in India helped define trends in onset correlated with urbanization and modern dietary changes. He pointed out the greatest incidence of type-2-diabetes occurs in India, China and the USA, respectively (1).
Their report does not discuss relative rates of onset in these countries other than the fact that world diabetes onset is doubling every 30 years, with 200 million people worldwide diagnosed to have this largely preventable disease.
Doughman commented on the quality and safety of algae oil and the global diabetes need. "Based on a full survey of the evidence-based literature, there is a tremendous opportunity for more omega-3 research from university groups. We report how algae oil significantly and safely benefits diabetics with dyslipidemias and elevated postprandial triglycerides, without introducing any known glucose control side effects or drug interactions in this population," he said.
Lead editor of the book compilation, Dr. Gottipolu R. Reddy, is Professor and Head, Division of Neuroscience, Department of Zoology, Sri Venkateswara University, Tirupati, India. Dr. Reddy is known internationally for his research in the area of developmental neurotoxicity of heavy metals. Dr. Reddy and Dr. Doughman met at a 2009 symposia at the historic Bangalore University, Department of Zoology, where each had been invited speakers.
High-DHA algae oil has no environmental pollutants, is natural cultured oil grown in enclosed controlled systems. The safety of high-DHA omega-3 algae oil intake by a type-2-diabetic was previously published on in review by Doughman et al., 2007 (2).
Other Source-Omega publications and articles in India on algae oil topics include peer reviewed manuscripts published in 2008 with the Indian Science Congress and in 2009 by the University of Madras, Department of Zoology. Recently Doughman's Visiting Faculty work has been written about by the Asian Scientist (3,4,5).
The company suggested that future studies on environmental pollution-effects will likely show significant contributions to diabetes onset worldwide, but acknowledged that algae oil DHA can only address the chronic dietary component of the disease.
Doughman commented, "Progress is being made in educating about the two sides of the type-2-diabetes coin, sugar and fat, not just sugar."
He then added, "We should not say the cause is the 'Western diet'. Diabetes is increasing with convenience diets, affluence, urbanization and possibly pollution. To say Western diet invites cultural blame and most diabetics do not eat a Western diet, rather refined sugars, starches and oils all play contributing roles as added ingredients in processed foods made all around the world."
Current science and consensus indicates eating fish is linked to lower blood glucose concentrations and the related associations to a reduced risk of developing diabetes, discovered as a result of the Prevention with a Mediterranean Diet study conducted by Mercedes Sotos Prieto in Spain through the University of Valencia. The study was conducted with the Valencia population involving 945 people (340 men and 605 women) between the ages of 55 to 80 who had high cardiovascular risk backgrounds.
Source-Omega is a member of the Global Organization for EPA and DHA Omega-3s (GOED), a trade group advocating for the ethical and sustainable use of omega-3 fatty acids in nutrition and medicine. GOED's website [http://www.goedomega3.com] suggests omega-3 prevention measures worldwide could help save $47 trillion in chronic disease costs, including the long term complications and costs associated with the diabetes epidemic.
(1) Doughman. A Substitute for Fish Oil: Qualifying Algae Oil Omega-3s as a Medical Food. (2011), in press, reprints available upon request.
(2) Doughman et al., Omega-3 fatty acids for nutrition and medicine: considering microalgae oil as a vegetarian source of EPA and DHA. Curr Diabetes Rev. (2007), 3:198-203
Chapel Hill, NC, February 02, 2011 --(PR.com)-- Source-Omega and its Pure One™ branded products are featured on the website of the Global Organization for EPA and DHA Omega-3s (GOED).
The company manufactures and markets Pure One™, the first and only US made Optimized Omega-3 DHA + EPA algae oil supplement formulation sold as a finished product. The Pure One™ omega-3 ratio is based on the science of human omega-3 metabolism.
The product range is kosher, vegan, infant formula grade and safe in all people, appropriate for those with type-2 diabetes, fish allergies, dietary restrictions and food sensitivities. Source-Omega uses only gluten-free, soy-free plant-based ingredients, all GMP processed in the USA.
The GOED Newsletter announced Source-Omega as the 108th member, with 5 new members listed after the First GOED Exchange in Salt Lake City, January 2011, attended by Source-Omega’s President and Chief Scientist, Dr Scott Doughman, PhD.
"Our product offerings are rapidly expanding the branded value of DHA+EPA from algae oil for international products," said Doughman.
The importance of DHA and EPA are well established and partly informed by the new Dietary Guidelines for Americans (DGA), which suggests “fortified foods and dietary supplements may be useful in providing one or more nutrients that otherwise may be consumed in less than recommend amounts.”
Government bodies like the Food and Drug Administration (FDA) and the American Heart Association (AHA) recognize the qualified use of DHA and EPA recommendations.
Source-Omega's qualified products meet GOED’s Monogram and strict ethics, which lend industry recognized credentials to the Pure One product.
“The Source-Omega company has made substantial contributions to the industry in only 3 years, plus our beautiful golden omega-3 oil is a leading international brand that drives awareness of pure algae oil for both DHA and EPA from one strain, Pure One, made without any chemical modifications for our differentiated, premium diabetic-friendly, nutraceutical supplement,” said Dr Doughman, who brought the Pure One™ branded innovations to the public in early 2008.
Source-Omega offers private labeling internationally in liquid oil, dietary supplements and medical food. Source-Omega’s plant-based algae omega-3 DHA + EPA products were first formulated by Dr. Scott Doughman in early 2007 while engaged in Omega-3 research at the University of North Carolina’s School of Public Health, funded by the National Institutes of Health.
Source-Omega is located in Chapel Hill, North Carolina, in historic Chatham County, and offers its patent pending omega-3 products made using an advanced vegetarian softgel technology combined with select algae oil grown in the USA.